Aperio Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $838K | Buy |
7,482
+297
| +4% | +$33.3K | ﹤0.01% | 1691 |
|
2020
Q3 | $565K | Sell |
7,185
-12
| -0.2% | -$944 | ﹤0.01% | 1748 |
|
2020
Q2 | $518K | Sell |
7,197
-1,058
| -13% | -$76.1K | ﹤0.01% | 1755 |
|
2020
Q1 | $473K | Sell |
8,255
-790
| -9% | -$45.3K | ﹤0.01% | 1679 |
|
2019
Q4 | $1.01M | Buy |
9,045
+584
| +7% | +$65.3K | ﹤0.01% | 1430 |
|
2019
Q3 | $814K | Buy |
8,461
+896
| +12% | +$86.2K | ﹤0.01% | 1503 |
|
2019
Q2 | $647K | Buy |
7,565
+108
| +1% | +$9.24K | ﹤0.01% | 1638 |
|
2019
Q1 | $620K | Buy |
7,457
+1,379
| +23% | +$115K | ﹤0.01% | 1620 |
|
2018
Q4 | $390K | Buy |
6,078
+543
| +10% | +$34.8K | ﹤0.01% | 1827 |
|
2018
Q3 | $438K | Buy |
5,535
+433
| +8% | +$34.3K | ﹤0.01% | 1834 |
|
2018
Q2 | $373K | Buy |
5,102
+166
| +3% | +$12.1K | ﹤0.01% | 1901 |
|
2018
Q1 | $313K | Buy |
4,936
+100
| +2% | +$6.34K | ﹤0.01% | 1938 |
|
2017
Q4 | $246K | Sell |
4,836
-69
| -1% | -$3.51K | ﹤0.01% | 2056 |
|
2017
Q3 | $257K | Sell |
4,905
-129
| -3% | -$6.76K | ﹤0.01% | 2006 |
|
2017
Q2 | $256K | Buy |
5,034
+487
| +11% | +$24.8K | ﹤0.01% | 1976 |
|
2017
Q1 | $202K | Sell |
4,547
-2,462
| -35% | -$109K | ﹤0.01% | 2034 |
|
2016
Q4 | $310K | Sell |
7,009
-106
| -1% | -$4.69K | ﹤0.01% | 1777 |
|
2016
Q3 | $285K | Buy |
7,115
+1,778
| +33% | +$71.2K | ﹤0.01% | 1741 |
|
2016
Q2 | $255K | Sell |
5,337
-737
| -12% | -$35.2K | ﹤0.01% | 1731 |
|
2016
Q1 | $255K | Buy |
+6,074
| New | +$255K | ﹤0.01% | 1741 |
|
2015
Q3 | – | Sell |
-3,680
| Closed | -$214K | – | 1950 |
|
2015
Q2 | $214K | Buy |
+3,680
| New | +$214K | ﹤0.01% | 1821 |
|